95 related articles for article (PubMed ID: 21888028)
1. Clinical diagnostic performance of different methods for the detection of antibodies to extractable nuclear antigens in connective tissue diseases: a cohort study.
Lora PS; Laurino CC; Becker BS; Monticielo OA; Brenol JC; Xavier RM
Clin Lab; 2011; 57(7-8):625-9. PubMed ID: 21888028
[TBL] [Abstract][Full Text] [Related]
2. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
4. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice.
Ulvestad E; Kanestrøm A; Madland TM; Thomassen E; Haga HJ; Vollset SE
Scand J Immunol; 2000 Sep; 52(3):309-15. PubMed ID: 10972909
[TBL] [Abstract][Full Text] [Related]
7. [The clinical immunology laboratory in diagnosis and monitoring of systemic lupus erythematosus and connective tissue diseases].
Sinico RA; Radice A
G Ital Nefrol; 2005; 22 Suppl 33():S21-6. PubMed ID: 16419001
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
[TBL] [Abstract][Full Text] [Related]
9. From ANA to ENA: how to proceed?
Damoiseaux JG; Tervaert JW
Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
[TBL] [Abstract][Full Text] [Related]
10. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
11. A rapid screening enzyme linked immunosorbent assay for autoantibodies to extractable nuclear antigens.
Warlow R; Carrano J; Dawkins R
Diagn Immunol; 1984; 2(3):154-60. PubMed ID: 6437732
[TBL] [Abstract][Full Text] [Related]
12. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.
Albon S; Bunn C; Swana G; Karim Y
J Immunol Methods; 2011 Feb; 365(1-2):126-31. PubMed ID: 21184759
[TBL] [Abstract][Full Text] [Related]
13. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
[TBL] [Abstract][Full Text] [Related]
14. Distribution of IgG subclass antibodies anti-ENA (extractable nuclear antigens) in systemic rheumatic diseases.
Sánchez Ibarrola A; Valdivieso R; Wong E; Sánchez Arroyo R
Allergol Immunopathol (Madr); 1987; 15(4):195-200. PubMed ID: 3500626
[TBL] [Abstract][Full Text] [Related]
15. Use of ELISA to measure antinuclear antibodies in children with juvenile rheumatoid arthritis.
Fawcett PT; Rose CD; Gibney KM; Emerich MJ; Athreya BH; Doughty RA
J Rheumatol; 1999 Aug; 26(8):1822-6. PubMed ID: 10451083
[TBL] [Abstract][Full Text] [Related]
16. [Anti-ENA antibody determination in various connective tissue diseases: comparison of 2 detection techniques].
Vaccai D; Cataldi V; Morozzi G; Bacarelli MR; Ciali A; Pucci G; Marcolongo R
Boll Soc Ital Biol Sper; 1993 Jan; 69(1):45-8. PubMed ID: 8329190
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a multiple nuclear dots pattern in a large cohort of dermatological patients.
Cozzani E; Drosera M; Riva S; Parodi A
Clin Lab; 2012; 58(3-4):329-32. PubMed ID: 22582508
[TBL] [Abstract][Full Text] [Related]
18. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.
Yu L; Wang J; O'Dell JR; Oates J; Arend WP; Eisenbarth GS
J Rheumatol; 2007 Apr; 34(4):734-9. PubMed ID: 17407230
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of antinuclear antibodies in connective tissue disease.
Pahor A; Krajnc I; Gorenjak M; Holc I
Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D;
Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]